Doctors implanted a microchip into a paralyzed patient's brain as part of a clinical trial giving people the ability to ...

Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma"), a clinical-stage biopharmaceutical company dedicated to innovative drug development for liver and central nervous system (CNS) diseases, today ...

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

A new drug originally developed to treat a different brain disease is now showing signs that it could help people with ...

Brain-machine interfaces (BMIs) are becoming lifelines for people facing severe motor impairments. For many individuals with conditions like amyotrophic lateral sclerosis (ALS) or spinal cord injuries ...

Unlike other interfaces—which sound stiff and robotic, like early smart assistants—this one imitates the sound and cadence of ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

Tech billionaire Elon Musk’s Neuralink is one of the most talked about players in the BCI field, but the first product to ...

Unlike previous systems that convert brain signals into text, this BCI synthesizes actual speech almost instantaneously. The ...

Recent brain-computer-interface (BCI) devices have made it possible to translate neural activity directly into text and even speech. Unfortunately, these systems had significant latency, often ...

People who can no longer move or speak may soon have a new option: an implanted device that links their brain to a computer.

An iPSC-based ALS-on-a-chip model that mimics disease progression and reveals altered glutamate signaling in motor neurons ...